These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14742777)

  • 1. Drug control authorities in China.
    Zhen LH
    Ann Pharmacother; 2004 Feb; 38(2):346-50. PubMed ID: 14742777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review and challenges of policies of environmental protection and sustainable development in China.
    Zhang KM; Wen ZG
    J Environ Manage; 2008 Sep; 88(4):1249-61. PubMed ID: 17767999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. China's new drug R&D is steadily advancing.
    Xu WF
    Drug Discov Ther; 2007 Aug; 1(1):3. PubMed ID: 22504356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The food industry and provincial economies.
    Walsh G; Li D
    Asia Pac J Clin Nutr; 2004; 13(2):166-70. PubMed ID: 15228984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Looking for a solution for drug addiction in China: exploring the challenges and opportunities in the way of China's new Drug Control Law.
    Liu Y; Liang J; Zhao C; Zhou W
    Int J Drug Policy; 2010 May; 21(3):149-54. PubMed ID: 19896818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exporting dams: China's hydropower industry goes global.
    McDonald K; Bosshard P; Brewer N
    J Environ Manage; 2009 Jul; 90 Suppl 3():S294-302. PubMed ID: 18992986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydropower and sustainability: resilience and vulnerability in China's powersheds.
    McNally A; Magee D; Wolf AT
    J Environ Manage; 2009 Jul; 90 Suppl 3():S286-93. PubMed ID: 19013007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals.
    Meng Q; Cheng G; Silver L; Sun X; Rehnberg C; Tomson G
    Health Policy Plan; 2005 May; 20(3):185-96. PubMed ID: 15840634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. China's drug innovation and policy environment.
    Liang H; Ding J; Xue Y
    Drug Discov Today; 2011 Jan; 16(1-2):1-3. PubMed ID: 20546920
    [No Abstract]   [Full Text] [Related]  

  • 10. Industrial sustainability in China: practice and prospects for eco-industrial development.
    Fang Y; Côté RP; Qin R
    J Environ Manage; 2007 May; 83(3):315-28. PubMed ID: 16814924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agro-food industry growth and obesity in China: what role for regulating food advertising and promotion and nutrition labelling?
    Hawkes C
    Obes Rev; 2008 Mar; 9 Suppl 1():151-61. PubMed ID: 18307719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the state/market dichotomy: Institutional innovations in China's electricity industry reform.
    Yu Z
    J Environ Manage; 2020 Jun; 264():110306. PubMed ID: 32217307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical policy in China.
    Sun Q; Santoro MA; Meng Q; Liu C; Eggleston K
    Health Aff (Millwood); 2008; 27(4):1042-50. PubMed ID: 18607039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. China's heath care system and avian influenza preparedness.
    Kaufman JA
    J Infect Dis; 2008 Feb; 197 Suppl 1():S7-13. PubMed ID: 18269328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of developmental and reproductive toxicity risk assessment in China.
    Wang H; Wang Q; Liao M
    Birth Defects Res B Dev Reprod Toxicol; 2010 Feb; 89(1):2-8. PubMed ID: 20077514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of Bio-pharmaceutical industry in China: problems and solutions.
    Yan G
    Pak J Pharm Sci; 2014 Jul; 27(4 Suppl):1035-9. PubMed ID: 25016263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injury control: an opportunity for China.
    Hu G; Baker TD; Li G; Baker SP
    Inj Prev; 2008 Apr; 14(2):129-30. PubMed ID: 18388234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health technology assessment development in China.
    Chen Y; Banta D; Tang Z
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():202-9. PubMed ID: 19575825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.